Theodore Sunki Hong MD

Radiation Oncology•Boston, MA

Gastrointestinal Cancer

Professor, Radiation Oncology-Massachusetts General Hospital, Harvard Medical School

Join to View Full Profile

100 Blossom StRadiation OncologyBoston, MA 02114
Phone+1 617-726-6050
Fax+1 617-726-3603

Summary

Dr. Theodore Hong is a radiation oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital, Emerson Hospital, and Newton-Wellesley Hospital. He received his medical degree from University of Connecticut School of Medicine and has been in practice 17 years. He specializes in gastrointestinal cancer.

Education & Training

University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 2001 - 2005
University of Wisconsin Hospitals and ClinicsInternship, Internal Medicine, 2000 - 2001
Uconn School Of MedicineClass of 2000

Certifications & Licensure

MA State Medical License 2005 - 2025
ME State Medical License 2020 - 2025
NH State Medical License 2021 - 2025
RI State Medical License 2020 - 2022
WI State Medical License 2004 - 2009
American Board of Radiology Radiation Oncology

Clinical Trials

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer Start of enrollment: 2007 Dec 01
Completed
Phase 1, Phase 2
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases Start of enrollment: 2003 Jun 01
Completed
Not Applicable
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma Start of enrollment: 2009 Aug 01
Completed
Not Applicable
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer Start of enrollment: 2010 Mar 01
Terminated
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Individualized Stereotactic Body Radiotherapy of Liver Metastases Start of enrollment: 2010 Jun 01
Completed
Not Applicable
Midostaurin (PKC412) for Locally Advanced Rectal Cancer Start of enrollment: 2011 Aug 01
Completed
Phase 1
Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer Start of enrollment: 2011 Dec 01
Active, not recruiting
Phase 2
FOLFIRINOX + RT for Pancreatic Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 2
Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer Start of enrollment: 2013 Jul 01
Active, not recruiting
Phase 2
Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer Start of enrollment: 2014 Sep 29
Terminated
Phase 3
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma Start of enrollment: 2014 Oct 01
Terminated
Not Applicable
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer Start of enrollment: 2017 May 10
Recruiting
Phase 2
Preoperative Radiotherapy and E7046 in Rectum Cancer Start of enrollment: 2017 May 17
Completed
Phase 1
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers Start of enrollment: 2017 Oct 24
Active, not recruiting
Phase 1
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer Start of enrollment: 2018 May 14
Recruiting
Phase 2
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer Start of enrollment: 2018 Aug 10
Active, not recruiting
Phase 2
Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement Start of enrollment: 2019 Mar 19
Recruiting
Not Applicable
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer Start of enrollment: 2019 Dec 31
Withdrawn
Join now to see all

Publications & Presentations

PubMed

Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinoma.
Stephanie O Dudzinski, Neil B Newman, Jeff McIntyre, Reena Engineer, Nina N Sanford
The Lancet. Gastroenterology & Hepatology. 2025-04-01
Utilizing Patient Input in Rectal Cancer Trial Design.
Janet Alvarez, Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher
Journal of the National Cancer Institute. 2025-03-19
3 citations
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy.
Nina N Sanford, Amol K Narang, Todd A Aguilera, Michael F Bassetti, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15

Journal Articles

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer
Harvey J Mamon, Paul L Nguyen, Theodore S Hong, Aparna Parikh, Jennifer Y Wo, Rinaa S Punglia, Cristina Ferrone, Ryan D Nipp, Annals of Surgical Oncology

Lectures

A pilot study of durvalumab/tremelimumab (durva/treme) and radiation (XRT) for metastatic biliary tract cancer (mBTC): Preliminary safety and efficacy.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Against - Debate: This House Believes FLOT Is the Standard Treatment for Fit Patients With T3N1 GEJ...
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
Pre/Post-Operative Chemo-Radiation
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Advances in Cancer Management for the Surgeon
Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 10/31/2012
Join now to see all

Press Mentions

Understanding Stage 4 Esophageal CancerNovember 15th, 2024
IntraOp® Announces First Patient Enrolled in PACER Trial for Pancreatic CancerMay 9th, 2019
Failure Is Not an OptionSeptember 17th, 2018
Join now to see all

Grant Support

Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.MASSACHUSETTS GENERAL HOSPITAL2021–2026
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.MASSACHUSETTS GENERAL HOSPITAL2021–2026

Theodore Sunki Hong MD

Dr. Hong is on Doximity

Summary

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.